MOUWASAT MEDICAL SERVICES COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136.4 SAR | -1.30% |
|
+1.34% | +22.00% |
| Sales 2024 * | 3.14B 837M | Sales 2025 * | 3.57B 953M | Capitalization | 27.28B 7.28B |
|---|---|---|---|---|---|
| Net income 2024 * | 851M 227M | Net income 2025 * | 921M 246M | EV / Sales 2024 * | 8.75 x |
| Net Debt 2024 * | 187M 49.88M | Net Debt 2025 * | 346M 92.41M | EV / Sales 2025 * | 7.73 x |
| P/E ratio 2024 * |
34.6
x | P/E ratio 2025 * |
29.9
x | Employees | 2,389 |
| Yield 2024 * |
1.85% | Yield 2025 * |
2.04% | Free-Float | 47.5% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.30% | ||
| 1 week | +1.34% | ||
| Current month | -1.02% | ||
| 1 month | +10.18% | ||
| 3 months | +17.38% | ||
| 6 months | +36.40% | ||
| Current year | +22.00% |
1 week
132.20
144.00
1 month
121.80144.00
Current year
112.40144.00
1 year
92.50144.00
3 years
79.40144.00
5 years
34.15144.00
10 years
22.50144.00
| Managers | Title | Age | Since |
|---|---|---|---|
Nasser Al-Subaie
CEO | Chief Executive Officer | - | 06-01-23 |
Yousef Suleiman
DFI | Director of Finance/CFO | - | 17-01-03 |
| Director/Board Member | - | 20-01-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 20-01-03 | |
Nasser Al-Subaie
CEO | Chief Executive Officer | - | 06-01-23 |
| Director/Board Member | 56 | 20-01-03 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.04% | 2,808 M€ | +2.67% | - | |
| 0.04% | 441 M€ | +1.71% | - | |
| 0.04% | 149 M€ | -1.09% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 136.4 | -1.30% | 283,897 |
| 24-04-17 | 138.2 | -1.29% | 443,419 |
| 24-04-16 | 140 | +0.72% | 473,386 |
| 24-04-15 | 139 | +2.96% | 435,008 |
End-of-day quote Saudi Arabian S.E., April 17, 2024
More quotes
Mouwasat Medical Services Company is a Saudi Arabia-based company, which is engaged, through its multiple branches, in the acquisition, management, operation and maintenance of hospitals, medical centers, drug stores, pharmacies and wholesale of medical equipment and drugs. The Company operates in two segments: medical services segment, which includes Inpatient and outpatient services and pharmaceuticals segments. The Company also operates specialize centers, which include Long term care, rehabilitation center, stroke unit, cardiology center, nuclear medicine, fertility, skin care and badana clinic, among others. The Company operates approximately 9 branches and The Companyââ¬â¢s subsidiaries includes Eastern Medical Services Company Limited and Jeddah Doctors Company.
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
136.4
SAR
Average target price
124
SAR
Spread / Average Target
-9.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.00% | 7.27B | |
| -23.26% | 15.64B | |
| 0.00% | 11.97B | |
| +1.49% | 11.27B | |
| +8.16% | 10.64B | |
| +18.74% | 7.93B | |
| -4.79% | 7.36B | |
| +5.39% | 6.73B | |
| -1.16% | 4.42B | |
| +46.35% | 4.52B |
- Stock Market
- Equities
- 4002 Stock
